Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Recruiting now

Conditions studied: Invasive Fungal Infections

In brief

This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.

Key facts

Study ID

NCT06105411

Run by

Peter MacCallum Cancer Centre, Australia

People needed

10

Starts

2023-12-01

Expected to finish

2027-04-01

Last updated by the study team

2025-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has provided written informed consent
• Aged 18 years or older at written informed consent
• Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria
• Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter
• Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up

You may not qualify if…

• Women who are pregnant or lactating.
• Iron infusion within one week prior to scan

Where it is running

• Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.